Skip to content

Poor weight gain during first year of ART associated with increased mortality risk for children with HIV in resource-limited settings

European HIV response "falling behind" as Eastern European epidemic grows

Reduced physical function significantly increases mortality risk of middle-aged people living with HIV

Safer injecting practices would be better promoted by focusing on pleasure and practical concerns – not the risk of infection

Sofosbuvir/ledipasvir with ribavirin cures most people with hepatitis C recurrence after liver transplantation

Sofosbuvir + simeprevir shows good results for hepatitis C in real-world use

Donald Jensen speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.

HIV epidemic will spring back without near-universal diagnosis and treatment, says UNAIDS

British HIV cure survey: most respondents would be prepared to take some health risk to help find a cure for HIV

DAAs show good cure rates and liver function improvement for transplant recipients with recurrent HCV

Robert Brown speaking at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting. Photo by Liz Highleyman, hivandhepatitis.com.